UBS lowered the firm’s price target on Leidos (LDOS) to $204 from $216 and keeps a Neutral rating on the shares. This quarter appears more selective, with more negative than positive stock reactions, even as commercial OE build rates continue to improve, demand remains strong, and supply chains look stable, supporting a shift toward normalized earnings valuations, the analyst tells investors in a research note. Aftermarket growth stays robust despite potential second-half deceleration risk, while Defense and Government IT performance may hinge more on budget and geopolitical narratives than near-term earnings catalysts, creating clear winners and laggards, UBS says.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LDOS:
- Leidos: VBA Profit Dependence and Rising Competition Temper Upside, Justifying Hold Rating
- Leidos price target raised to $232 from $218 at Citi
- Stifel downgrades Leidos on challenges to ‘key contract’ in 2026
- Leidos downgraded to Hold from Buy at Stifel
- Trump Trade: 350 drugs to see price raises despite President’s pressure
